Neuronetics Inc (NASDAQ:STIM) price on Wednesday, November 13, fall -11.65% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.61.
A look at the stock’s price movement, the close in the last trading session was $0.69, moving within a range at $0.58 and $0.69. The beta value (5-Year monthly) was 2.216. Turning to its 52-week performance, $5.07 and $0.52 were the 52-week high and 52-week low respectively. Overall, STIM moved -31.51% over the past month.
Neuronetics Inc’s market cap currently stands at around $18.47 million, with investors looking forward to this quarter’s earnings report slated for in December.
Analysts have a consensus estimate of 18.95M for the company’s revenue for the quarter, with a low and high estimate of 18.6M and 19.2M respectively. The average forecast suggests down to a -6.74% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 71.31M, representing a -0.05% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that STIM is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
2 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 2 recommend STIM as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
STIM’s current price about -39.05% and -32.07% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 30.80, while 7-day volatility ratio is 21.17% and 10.35% in the 30-day chart. Further, Neuronetics Inc (STIM) has a beta value of 2.20, and an average true range (ATR) of 0.12. Analysts have given the company’s stock an average 52-week price target of $8, forecast between a low of $8 and high of $8. Looking at the price targets, the low is -1211.48% off current price level while to achieve the yearly target high, price needs to move -1211.48%. Nonetheless, investors will most likely welcome a -1211.48% jump to $8 which is the analysts’ median price.
If we refocus on Neuronetics Inc (NASDAQ:STIM), historical trading data shows that trading volumes averaged 1.05 over the past 10 days and 444.13K over the past 3 months. The company’s latest data on shares outstanding shows there are 29.09 million shares.
The 7.69% of Neuronetics Inc’s shares are in the hands of company insiders while institutional holders own 48.35% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.74 million on 2024-10-31, giving us a short ratio of 4.05. The data shows that as of 2024-10-31 short interest in Neuronetics Inc (STIM) stood at 258.99999 of shares outstanding, with shares short rising to 0.56 million registered in 2024-09-30. Current price change has pushed the stock -78.98% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the STIM stock continues to rise going into the next quarter.
